Suppr超能文献

终末期肾病患者的导管相关血流感染:一项加拿大的叙述性综述

Catheter-related bloodstream infection in end-stage kidney disease: a Canadian narrative review.

作者信息

Lata Chris, Girard Louis, Parkins Michael, James Matthew T

机构信息

Division of Infectious Diseases, Department of Medicine, University of Calgary, Calgary, Canada.

Division of Nephrology, Department of Medicine, University of Calgary, Calgary, AB T2N 2T9 Canada.

出版信息

Can J Kidney Health Dis. 2016 May 5;3:24. doi: 10.1186/s40697-016-0115-8. eCollection 2016.

Abstract

PURPOSE OF THE REVIEW

Patients with end-stage renal disease (ESRD) are at a high risk of bacterial infection. We reviewed publications on risk factors, prevention, and treatment paradigms, as well as outcomes associated with bacterial infection in end-stage kidney disease. We focused in particular on studies conducted in Canada where rates of haemodialysis catheter use are high.

SOURCES OF INFORMATION

We included original research articles in English text identified from MEDLINE using search terms 'chronic kidney failure', 'renal dialysis', or 'chronic renal insufficiency', and 'bacterial infection'. We focused on articles with Canadian study populations and included comparisons to international standards and outcomes where possible.

FINDINGS

Bacterial infections in this setting are most commonly due to Gram-positive skin flora, particularly Staphylococcus, with methicillin-resistant Staphylococcus aureus (MRSA) carrying a poorer prognosis. Interventions that may decrease mortality from sepsis include a collaborative care model that includes a nephrology team, an infectious disease specialist, and use of standardized care bundles that adhere to proven quality-of-care indicators. Decreased infectious mortality may be achieved by ensuring appropriate antibiotic selection and dosing as well as avoiding catheter salvage attempts. Reduction in bloodstream infection (BSI) incidence has been observed with the use of tPA catheter-locking solutions and the use of mupirocin or polysporin as a topical agent at the catheter exit site, as well as implementing standarized hygiene protocols during catheter use.

LIMITATIONS

There has been a paucity of randomized controlled trials of prevention and treatment strategies for catheter-related BSIs in haemodialysis. Some past trials have been limited by lack of blinding and short duration of follow-up. Microbiological epidemiology, although well characterized, may vary by region and treatment centre.

IMPLICATIONS

With the high prevalence of catheter use in Canadian haemodialysis units, further studies on long-term treatment and preventative strategies for BSI are warranted.

摘要

综述目的

终末期肾病(ESRD)患者发生细菌感染的风险很高。我们回顾了关于终末期肾病患者细菌感染的危险因素、预防和治疗模式以及相关结局的文献。我们特别关注在加拿大进行的研究,该国血液透析导管的使用率很高。

信息来源

我们纳入了从MEDLINE中检索到的英文原文研究文章,检索词为“慢性肾衰竭”“肾透析”或“慢性肾功能不全”以及“细菌感染”。我们重点关注有加拿大研究人群的文章,并尽可能纳入与国际标准和结局的比较。

研究结果

这种情况下的细菌感染最常见于革兰氏阳性皮肤菌群,尤其是葡萄球菌,耐甲氧西林金黄色葡萄球菌(MRSA)的预后较差。可能降低脓毒症死亡率的干预措施包括一种协作护理模式,该模式包括肾脏病团队、传染病专家,以及使用遵循已证实的护理质量指标的标准化护理包。通过确保适当的抗生素选择和剂量以及避免导管挽救尝试,可降低感染死亡率。使用组织型纤溶酶原激活剂(tPA)导管封管溶液、在导管出口部位使用莫匹罗星或多粘菌素作为局部用药,以及在使用导管期间实施标准化卫生协议,已观察到血流感染(BSI)发生率有所降低。

局限性

血液透析中导管相关BSI预防和治疗策略的随机对照试验较少。过去的一些试验受到缺乏盲法和随访时间短的限制。微生物流行病学虽然特征明确,但可能因地区和治疗中心而异。

启示

鉴于加拿大血液透析单位导管使用率很高,有必要对BSI的长期治疗和预防策略进行进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c71c/4857243/cf6ded17a63d/40697_2016_115_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验